Veritable, L.P. Amgen Inc Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $141,203 - $166,970	-659 Reduced 2.02%	31,930 $7.09 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $312,493 - $380,876	-1,384 Reduced 4.07%	32,589 $7.88 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $12,596 - $16,005	55 Added 0.16%	33,973 $8.92 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $482,140 - $543,766	-2,148 Reduced 5.96%	33,918 $7.65 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $318,610 - $354,557	1,381 Added 3.98%	36,066 $8.78 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $950,096 - $1.05 Million	4,333 Added 14.28%	34,685 $8.39 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $479,698 - $548,971	-2,412 Reduced 7.36%	30,352 $6.83 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $835,494 - $978,883	3,936 Added 13.65%	32,764 $6.97 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $1.27 Million - $1.4 Million	5,417 Added 23.14%	28,828 $7.03 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $328,426 - $382,728	1,480 Added 6.75%	23,411 $5.83 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $336,254 - $400,419	-1,554 Reduced 6.62%	21,931 $5.04 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $97,614 - $108,555	-416 Reduced 1.74%	23,485 $5.97 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $168,731 - $207,057	-853 Reduced 3.45%	23,901 $5.64 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $85,835 - $113,840	-471 Reduced 1.87%	24,754 $5.02 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $95,172 - $122,329	503 Added 2.03%	25,225 $6.08 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $75,911 - $90,958	436 Added 1.8%	24,722 $4.78 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $40,341 - $47,289	242 Added 1.01%	24,286 $4.48 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $43,227 - $48,727	-239 Reduced 0.98%	24,044 $4.57 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $83,669 - $97,669	-469 Reduced 1.89%	24,283 $4.73 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $93,942 - $105,907	507 Added 2.09%	24,752 $5.13 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $26,069 - $29,282	157 Added 0.65%	24,245 $4.48 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $16,773 - $19,602	99 Added 0.41%	24,088 $4.11 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $507,382 - $566,901	-3,006 Reduced 11.14%	23,989 $4.17 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $4.52 Million - $5.16 Million	26,995	26,995 $5.03 Million

Others Institutions Holding AMGN

# of Institutions

3,213

Shares Held

422M

Call Options Held

7.05M

Put Options Held

6.39M

Vanguard Group Inc Valley Forge, PA

52.7M
Shares

$14.6 Billion
0.25% of portfolio
Black Rock Inc. New York, NY

46M
Shares

$12.8 Billion
0.33% of portfolio
State Street Corp Boston, MA

29.4M
Shares

$8.16 Billion
0.31% of portfolio
Morgan Stanley New York, NY

14.6M
Shares

$4.04 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

13.2M
Shares

$3.66 Billion
0.65% of portfolio

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $148B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account